NCT03005691

Brief Summary

The purpose of this study is to determine whether the metabolite concentrations within the anterior cingulate cortex and periaqueductal gray matter predict the intensity and interference of neuropathic pain after the development of chronic whiplash syndrome.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2017

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2016

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 29, 2016

Completed
3 days until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

December 29, 2016

Status Verified

December 1, 2016

Enrollment Period

2 months

First QC Date

December 15, 2016

Last Update Submit

December 28, 2016

Conditions

Keywords

metabolitecentral sensitizationwhiplash

Outcome Measures

Primary Outcomes (6)

  • Metabolite concentrations

    The metabolite concentrations will be measured by magnetic resonance (spectroscopy)

    Baseline at 0 min

  • Conditioned Pain Modulation

    Conditioned Pain Modulation will be measured by a Pathway system (Medoc Ltd)

    Baseline at 0 min

  • Brief Pain Inventory

    Brief Pain Inventory (BPI), it is used to evaluate the subject's perception of pain severity and its interference.

    Baseline at 0 min

  • Neurophatic Pain Symptoms Inventory

    Neurophatic Pain Symptoms Inventory (NPSI), it is used to detect paresthesia/dysaesthesia, evoked pain and paroxysmal pain.

    Baseline at 0 min

  • Pain Catastrophizing Helplessness Subscale

    Pain Catastrophizing Helplessness Subscale it is used to assess the catastrophizing score

    Baseline at 0 min

  • Neck Disability Index

    Neck Disability Index (NDI), it is used to assess the disability after whiplash syndrome

    Baseline at 0 min

Study Arms (3)

Whiplash-Pain

Subjects with chronic whiplash syndrome and pain. The inclusion criteria for pain include the presence of daily pain during the previous 8 weeks. Specifically, pain will be diagnosed based on the pain intensity measured on the 0 to 10 numerical rating scale. The minimum will be 2 points. Subjects will be recruited between the 4 months until 2 years after the whiplash.

Radiation: SpectroscopyOther: QuestionnairesProcedure: Conditioned Pain Modulation

Whiplash-no Pain

Subjects with chronic whiplash syndrome and pain. The inclusion criteria for pain include the ausence of daily pain during the previous 8 weeks. Specifically, pain will be diagnosed based on the pain intensity measured on the 0 to 10 numerical rating scale. The maximun will be 2 points. Subjects will be recruited between the 4 months until 2 years after the whiplash.

Radiation: SpectroscopyOther: QuestionnairesProcedure: Conditioned Pain Modulation

Non-injured

Subjects without whiplash syndrome. The inclusion criteria are defined as a absence of previous or actual symptoms or signs of neck pain.

Radiation: SpectroscopyOther: QuestionnairesProcedure: Conditioned Pain Modulation

Interventions

SpectroscopyRADIATION

Spectroscopy is a noninvasive method to assess brain chemistry. The signal of the hydrogen atom attached to a certain molecule or metabolite has a particular frequency associated with a given metabolite. The utility of Spectroscopy is based on the fact thet the nuclei of atoms have magnetic properties that can be used to obtain chemical information regarding both the type of molecule and it is concentration. The subjects will be scanned on a 3-T Siemens system and an 12-channel phased-array coil will be used to provide an optimum signal-to-noise ratio for spectroscopy data.

Non-injuredWhiplash-PainWhiplash-no Pain

Questionnaires are important to assess the chronic pain and their impact in the quality of life. For this reason, we will assess the Brief Pain Inventory (BPI), it is used to evaluate the subject's perception of pain severity and its interference. Moreover, we will assess neuropathic pain symptoms with the NPSI to detect paresthesia/dysaesthesia, evoked pain and paroxysmal pain. The catastrophizing score will be measured with the Pain Catastrophizing Helplessness Subscale. Also,we will assess the disability after whiplash using the Neck Disability Index.

Non-injuredWhiplash-PainWhiplash-no Pain

Conditioned Pain Modulation over the tenar eminence. The test will be a heat tonic stimulus which evoke a 3-pain intensity. The conditioning stimulus will be a cold water immersion (12ºC)

Non-injuredWhiplash-PainWhiplash-no Pain

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who have suffered whiplash syndrome. By one hand, patients with chronic pain (minimun 8 weeks) and 2 points or more of pain intensity. By the other hand, patiens without pain (2 points or less of pain intensity). By last, subjects without whiplash syndrome.

You may qualify if:

  • Whiplash syndrome
  • Chronic pain
  • Age between 18 to 65 years
  • months to 2 years after the whiplash syndrome

You may not qualify if:

  • Neurological disease
  • Claustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Chronic PainWhiplash Injuries

Interventions

Spectrum AnalysisSurveys and Questionnaires

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNeck InjuriesWounds and Injuries

Intervention Hierarchy (Ancestors)

Chemistry Techniques, AnalyticalInvestigative TechniquesData CollectionEpidemiologic MethodsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Diego Serrano-Muñoz, MsC

    Hospital Nacional de Parapléjicos, Toledo

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Julian Taylor-Green, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2016

First Posted

December 29, 2016

Study Start

January 1, 2017

Primary Completion

March 1, 2017

Study Completion

May 1, 2017

Last Updated

December 29, 2016

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will share

To publish in impact journals